• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过抗T细胞单克隆抗体评估黑色素瘤患者的T细胞亚群。

T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.

作者信息

Bernengo M G, Lisa F, Puiatti P, Meregalli M, Berruto G, Zina G

出版信息

Thymus. 1983 Apr;5(3-4):223-33.

PMID:6224319
Abstract

Functional T-cell subpopulations have been evaluated in the peripheral blood of 124 melanoma patients (71 non-metastatic and 53 metastatic) using monoclonal antibodies: OKT3, OKT4, OKT8, every 2 months for 1 year. The levels of OKT3+ cells were significantly lower in metastatic patients than in normal controls and they decreased in the advanced phases of the disease. Percentages and absolute OKT4+ cell values were reduced in metastatic patients only, while a significant reduction in OKT8+ cells was noted in both long-surviving, non-metastatic and metastatic patients. The ratio of OKT4+/OKT8+ cells was increased in non-metastatic patients and in patients remaining metastasis-free for 4 years after resection of their metastases. Patients with prolonged survival show normal T-helper cells and low T-suppressor cells with a significant increased ratio OKT4/OKT8. In the patients who developed visceral metastases and in those who died the progressive reduction in total T cells is mainly due to the decrease in OKT4+ cells.

摘要

使用单克隆抗体OKT3、OKT4、OKT8,对124例黑色素瘤患者(71例非转移性和53例转移性)的外周血中的功能性T细胞亚群进行了为期1年、每2个月一次的评估。转移性患者中OKT3 +细胞水平显著低于正常对照组,且在疾病晚期有所下降。仅转移性患者的OKT4 +细胞百分比和绝对值降低,而在长期存活的非转移性和转移性患者中均观察到OKT8 +细胞显著减少。非转移性患者以及转移灶切除后4年无转移的患者中,OKT4 + /OKT8 +细胞比值升高。长期存活的患者表现为正常的辅助性T细胞和低水平的抑制性T细胞,OKT4/OKT8比值显著增加。发生内脏转移的患者以及死亡患者中,总T细胞的逐渐减少主要是由于OKT4 +细胞的减少。

相似文献

1
T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.通过抗T细胞单克隆抗体评估黑色素瘤患者的T细胞亚群。
Thymus. 1983 Apr;5(3-4):223-33.
2
Use of monoclonal antibodies specific for T cell subsets in cutaneous disorders: I. Quantitative analysis of peripheral blood lymphocytes.皮肤疾病中针对T细胞亚群的单克隆抗体的应用:I. 外周血淋巴细胞的定量分析
J Clin Immunol. 1982 Jul;2(3 Suppl):103S-110S.
3
Differential recovery of circulating T cell subsets after nodal irradiation for Hodgkin's disease.霍奇金病淋巴结照射后循环T细胞亚群的差异恢复
J Immunol. 1984 Feb;132(2):1026-30.
4
Evaluation of T cell subsets with monoclonal antibodies in synovial fluid in rheumatoid arthritis.用单克隆抗体评估类风湿关节炎滑液中的T细胞亚群。
J Rheumatol. 1982 Nov-Dec;9(6):821-6.
5
Recognition of immature T-cell phenotypes in neonatal blood using monoclonal antibodies.利用单克隆抗体识别新生儿血液中未成熟的T细胞表型。
Diagn Immunol. 1983;1(3):205-10.
6
A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.对接受多药化疗的美拉尼西亚麻风患者,通过荧光麻风抗体吸收试验(FLA-ABS)测定其T细胞亚群和抗麻风杆菌抗体滴度的随访研究。
Int J Lepr Other Mycobact Dis. 1986 Mar;54(1):38-45.
7
[Study of blood T-lymphocyte subpopulations in ankylosing spondylarthritis using monoclonal antibodies].
Rev Rhum Mal Osteoartic. 1984 Jun;51(6):325-30.
8
[Analysis of circulating T-lymphocyte subpopulations with monoclonal antibodies in psoriasis].
Med Cutan Ibero Lat Am. 1985;13(4):341-5.
9
[Sub-populations of T helper suppressor lymphocytes in diverse dermatoses using monoclonal antibodies. Preliminary results (author's transl)].
Ann Dermatol Venereol. 1981;108(3):243-6, 249-50.
10
Effects of age, gender, and cigarette smoking on human immunoregulatory T-cell subsets: establishment of normal ranges and comparison with patients with colorectal cancer and multiple sclerosis.年龄、性别和吸烟对人类免疫调节性T细胞亚群的影响:正常范围的确定及与结直肠癌和多发性硬化症患者的比较。
Diagn Immunol. 1983;1(3):216-23.

引用本文的文献

1
Lymphocyte subsets as prognostic markers for cancer patients receiving immunomodulative therapy.淋巴细胞亚群作为接受免疫调节治疗的癌症患者的预后标志物。
Med Oncol. 1999 Sep;16(3):145-53. doi: 10.1007/BF02906126.